HOTH News and Press, Hoth Therapeutics Inc. From 03/24/21

Gainers: Aptose Biosciences (APTO) +65%, Brainstorm Cell Therapeutics (BCLI) +13%, Prothena (PRTA) +12%, Armata Pharmaceuticals (ARMP) +8%, Inventiva (IVA) +8%.Losers: Benitec Biopharma (BNTC) -24%, Second Sight Medical Products (EYES) -1...

HaloVax, a vaccine candidate targeting COVID-19 has demonstrated positive data from its second set of preclinical animal testing, Voltron Therapeutics said.Developed in partnership with Hoth Therapeutics (HOTH), HaloVax is built on a base of a heat shock protein (HSP70)-Avidin fusion pro...

NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced positive data from its second set of preclinical animal testing of its HaloVax™ Self-Assembling Vaccine (SAV) against COVID-19. This study investigated an updated construct, based on initial t...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Hoth Therapeutics (NASDAQ: HOTH ) stock are skyrocketing on Tuesday following positive preclinical results from the firm’s novel coronavirus treatment. Source: Shutterstock Hoth said that ...

Gainers: Benitec Biopharma (BNTC) +71%, Hoth Therapeutics (HOTH) +26%, Aerpio Pharmaceuticals (ARPO) +12%, Soliton (SOLY) +11%, China Jo-Jo Drugstores (CJJD) +9%.Losers: Frequency Therapeutics (FREQ) -75%, Windtree Therapeutics (WINT) ...

Hoth Therapeutics (HOTH) soars 56% premarket after announcing new in vitro data demonstrating SARS-CoV-2 antiviral activity for its lead peptide candidate for HT-002, a novel therapeutic targeted for the treatment of COVID-19. The lead HT-002 peptide candidate was shown to inhi...

Hoth Therapeutics Announces Positive Preclinical Results for Novel COVID-19 Therapeutic PR Newswire NEW YORK , March 23, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced new in vitro data demonstrat...

Hoth Therapeutics to Present at the Benzinga Biotech Small Cap Conference on March 24, 2021 Robb Knie, CEO, will also participate in a panel discussion entitled, 'Coming Together to Address Unmet Medical Needs' PR Newswire NEW YORK , March 22, 2021 /PRNewswir...

Hoth Therapeutics CEO, Robb Knie, Featured on the RedChip Money Report on Bloomberg TV this Saturday, March 20th PR Newswire NEW YORK , March 19, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a patient-focused clinical-stage biopharmaceutical...

Hoth Therapeutics (HOTH) announces entering into a Research Agreement with the University of Cincinnati Research Institute ("UCRI") to perform critical antimicrobial characterization studies with HT-006 as part of the streamlined drug development plan.HT-006 is a novel antibiot...